Taken together, our in vitro and in vivo MDS models exhibited the expansion of FBXO11-low MDS HSPCs and demonstrated their contribution to MDS progression through exacerbated neutropenia. The gene discussed is FBXO11; the disease is Decreased total neutrophil count.